Trouble brewing for Provention? Shares crater after FDA says their teplizumab drug profile doesn't match that from former owner Eli Lilly

Provention Bio acquired the former Eli Lilly drug teplizumab a few years ago, hoping to bring the experimental drug back from the dead in type …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Trou­ble brew­ing for Proven­tion? Shares crater af­ter FDA says their teplizum­ab drug pro­file does­n't match that from for­mer own­er Eli Lil­ly